Baidu
map

JACC:青少年心律失常性心肌病的表型研究

2019-07-27 不详 MedSci原创

心律失常性心肌病(ACM)在青少年中的发病率越来越高。本研究的目的旨在探究儿童和青少年ACM患者的不同基因型、表型和预后。本研究纳入了1999-2016年年龄<21岁的具有一致个人史或家族ACM病史的患者,最终共纳入了32名患者(平均年龄15.1±3.8),其中22名为先证者,包括16名右室型ACM,7名左室型和9名双心室型ACM患者。右室型与心脏猝死和室性心动过速(p=0.02)相关,也与PKP

心律失常性心肌病(ACM)在青少年中的发病率越来越高。本研究的目的旨在探究儿童和青少年ACM患者的不同基因型、表型和预后。

本研究纳入了1999-2016年年龄<21岁的具有一致个人史或家族ACM病史的患者,最终共纳入了32名患者(平均年龄15.1±3.8),其中22名为先证者,包括16名右室型ACM,7名左室型和9名双心室型ACM患者。右室型与心脏猝死和室性心动过速(p=0.02)相关,也与PKP2基因的突变相关(p < 0.01) ,而双心室型的与更早的发病年龄相关(p = 0.02)。左心室型与DSP和LMNA基因的突变相关。有10名患者接受了心脏移植手术,无死亡病例。另外,在右心室和双心室型的患者中,心电图的表型要早于影像学表型,而左心室型则相反。

研究结果显示,心律失常性心肌病在青少年中的表型多样,包括危及生命的心律失常、心力衰竭和心肌炎症。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1746375, encodeId=70b01e4637597, content=<a href='/topic/show?id=dc155099374' target=_blank style='color:#2F92EE;'>#心律失常性心肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50993, encryptionId=dc155099374, topicName=心律失常性心肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c5d35715733, createdName=luoxiaog, createdTime=Wed May 20 15:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854466, encodeId=a2c91854466f4, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Feb 08 20:26:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326291, encodeId=9ec01326291da, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535236, encodeId=483315352367e, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622401, encodeId=9fc8162240192, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1746375, encodeId=70b01e4637597, content=<a href='/topic/show?id=dc155099374' target=_blank style='color:#2F92EE;'>#心律失常性心肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50993, encryptionId=dc155099374, topicName=心律失常性心肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c5d35715733, createdName=luoxiaog, createdTime=Wed May 20 15:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854466, encodeId=a2c91854466f4, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Feb 08 20:26:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326291, encodeId=9ec01326291da, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535236, encodeId=483315352367e, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622401, encodeId=9fc8162240192, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=)]
    2020-02-08 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1746375, encodeId=70b01e4637597, content=<a href='/topic/show?id=dc155099374' target=_blank style='color:#2F92EE;'>#心律失常性心肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50993, encryptionId=dc155099374, topicName=心律失常性心肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c5d35715733, createdName=luoxiaog, createdTime=Wed May 20 15:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854466, encodeId=a2c91854466f4, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Feb 08 20:26:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326291, encodeId=9ec01326291da, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535236, encodeId=483315352367e, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622401, encodeId=9fc8162240192, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1746375, encodeId=70b01e4637597, content=<a href='/topic/show?id=dc155099374' target=_blank style='color:#2F92EE;'>#心律失常性心肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50993, encryptionId=dc155099374, topicName=心律失常性心肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c5d35715733, createdName=luoxiaog, createdTime=Wed May 20 15:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854466, encodeId=a2c91854466f4, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Feb 08 20:26:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326291, encodeId=9ec01326291da, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535236, encodeId=483315352367e, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622401, encodeId=9fc8162240192, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=)]
    2019-07-29 tastas
  5. [GetPortalCommentsPageByObjectIdResponse(id=1746375, encodeId=70b01e4637597, content=<a href='/topic/show?id=dc155099374' target=_blank style='color:#2F92EE;'>#心律失常性心肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50993, encryptionId=dc155099374, topicName=心律失常性心肌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c5d35715733, createdName=luoxiaog, createdTime=Wed May 20 15:26:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854466, encodeId=a2c91854466f4, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Feb 08 20:26:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326291, encodeId=9ec01326291da, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535236, encodeId=483315352367e, content=<a href='/topic/show?id=099f9020145' target=_blank style='color:#2F92EE;'>#表型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90201, encryptionId=099f9020145, topicName=表型)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6412593156, createdName=tastas, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622401, encodeId=9fc8162240192, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Jul 29 01:26:00 CST 2019, time=2019-07-29, status=1, ipAttribution=)]

相关资讯

JACC:青少年时期的血压和胆固醇水平与远期的心血管病风险相关!

血压和胆固醇是主要的心血管可调控危险因素,但年轻时期对危险因素的暴露对后期人生心血管风险的影响尚不清楚。本研究的目的旨在评估青少年时期对危险因素的暴露与晚期心血管疾病发生风险的相关性。本研究纳入分析了来自6个美国队列的36030名参与者,并记录分析其18岁及以后的低密度脂蛋白(LDL)、高密度脂蛋白(HDL)和血压。经过平均17年时间的随访,共发生4570件冠心病事件,5119件心衰事件和2862

JAMA子刊:警惕“苹果型”身材!即使BMI正常,也与全因死亡率、心血管和癌症死亡率风险增加相关

“苹果型”身材 - 即使体重指数(BMI)在正常范围内,也与腰围高的肥胖患者的全因死亡率、心血管和癌症死亡率风险增加相似。

JAHA:人口密度增加,可能带来心脏获益

随全球城市化程度不断加深,许多城市的人口密度迅速增加。人口密度增加对心血管健康会产生什么影响?带着这个疑问,研究人员对城市人口密度增加(城市人口致密化)对澳大利亚成人心血管危险因素的潜在影响展开调查,并将结果发表于近期出版的《美国心脏协会杂志》(Journal of the American Heart Association)。

NEJM连发两文:中国有能力做好全球创新药临床研究!

肾性贫血新希望,Roxadustat强势登场!收缩压与舒张压可独立预测心血管结局!

JACC:脉冲消融治疗房颤安全有效

使用射频或冷冻疗法等热能进行的心房颤动导管消融会造成组织的破坏。在脉冲消融(PFA)过程中,亚电场在细胞膜上产生微小的孔,这一过程称为电穿孔。在各种细胞类型中,心肌细胞具有最低阈值,可能允许优先心肌的消融。本研究的目的旨在评估PFA是否可以达到持久的肺静脉(PV)隔离而不损害侧支结构。本次两项临床试验探究了基于导管的PFA对发作性房颤的有效性和安全性。在所有的81名患者中,所有患者的肺静脉均被单相

JACC:急性暴发性心肌炎和非暴发性心肌炎的预后研究

急性暴发性心肌炎(FM)是一类以严重左室收缩功能不全为特征的心肌炎,预后差。一项单中心研究显示FM患者的预后较伴左室收缩功能不全的急性非暴发性心肌炎(NFM)患者更好。本研究的目的旨在进一步明确FM的预后。本研究纳入了220名(平均年龄42岁,女性占46.3%)病理证实为心肌炎且左室收缩功能不全的患者,其中165名为FM患者。主要终点事件是入院后60内的心源性死亡和预期随访后的心脏移植。与NFM患

Baidu
map
Baidu
map
Baidu
map